Aaron Coulon, MD
Dermatology · New Orleans, LANPI 1346773108
Payments from drug & device makers
Across 88 payments — averaging $29.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$457
- AbbVie$415
- Sun Pharmaceutical Industries Inc.$332
- Sanofi$202
- Novartis$175
- Galderma Laboratories, L.p.$166
- plus $810 from 17 others
What the payments were for
- Food & beverage$2,22887%
- Education$32913%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 10 | $457 |
| AbbVie(2 entities) | 15 | $415 |
| Sun Pharmaceutical Industries Inc. | 13 | $332 |
| Sanofi | 9 | $202 |
| Novartis | 9 | $175 |
| Galderma Laboratories, L.p. | 2 | $166 |
| E.r. Squibb & Sons, L.L.C. | 1 | $150 |
| LEO Pharma Inc. | 4 | $81 |
| Incyte Corporation | 3 | $76 |
| Regeneron Healthcare Solutions, Inc. | 3 | $76 |
| Sanofi-aventis U.S. LLC | 1 | $72 |
| Almirall LLC | 3 | $67 |
| EPI Health, LLC | 3 | $49 |
| Amgen | 2 | $48 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 2 | $35 |
| Organon | 1 | $25 |
| Helsinn Therapeutics (U.S.), Inc. | 1 | $23 |
| UCB, Inc. | 1 | $23 |
| Verrica Pharmaceuticals Inc. | 1 | $22 |
| VYNE Pharmaceuticals Inc. | 1 | $19 |
| Lilly USA, LLC | 1 | $16 |
| Pfizer | 1 | $15 |
| Nabriva Therapeutics, PLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,557 in reported general payments places this provider in the 30th percentile of 189 dermatology providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Skyrizi PenRisankizumab-Rzaa | 11 | $214,025 |
| Dupixent PenDupilumab | 21 | $80,157 |
| Pimecrolimus | 21 | $8,884 |
| Tacrolimus | 70 | $8,517 |
| Clobetasol Propionate | 258 | $7,059 |
| Ketoconazole | 271 | $5,132 |
| Betamethasone Dipropionate | 62 | $5,043 |
| Triamcinolone Acetonide | 180 | $2,783 |
| Fluorouracil | 31 | $2,594 |
| CiclopiroxCiclopirox Olamine | 91 | $2,325 |
| Hydrocortisone | 132 | $1,865 |
| Calcipotriene | 12 | $1,680 |
| Clindamycin Phosphate | 41 | $1,424 |
| Tretinoin | 17 | $1,405 |
| Doxycycline Hyclate | 69 | $1,272 |
Paid to pharmacies, not to this prescriber.
Other dermatology in New Orleans
- Deirdre HooperNew Orleans$3.2M
- Sarah JacksonNew Orleans$1.7M
- Erin BohNew Orleans$945K
- William ClaiborneNew Orleans$384K
- Mara HaseltineNew Orleans$276K
- Julie MermilliodNew Orleans$222K
- Patricia HickhamNew Orleans$12K
- Stephen KlingerNew Orleans$11K
- Jordan WhatleyBaton Rouge$27.9M
- Ira ThorlaBaton Rouge$5.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.